Frank Yu
Director
pharmaceutical
Hua Medicine
China
Biography
Frank is Founder, CEO and CIO of Ally Bridge Group, a global healthcare-focused investment group based in Hong Kong and the US, and of Themes Investment Partners, a China-focused private equity fund. On April 30, 2015, Frank's Ally Bridge Group announced a joint offer with Dr. Ge Li, Chairman, Founder and CEO of Wuxi Pharmatech (NYSE: WX) and co-founder and director of Hua Medicine, to take Wuxi private for USD3.3 billion, the largest healthcare private equity deal in Asia ex-Japan. The landmark Wuxi deal was successfully completed on December 10, 2015 and Frank joins the board of Wuxi as a director.
Research Interest
pharmaceutical
